EPCAM and non-small cell lung carcinoma: One of the first reports on CTC analysis in stage I–III NSCLC demonstrated that the CTC detection rate obtained by the capture of cells expressing EpCAM and cytokeratins 8/18/19 was lower compared to parallel samples analyzed by a size-based isolation approach coupled to cytomorphological analysis [32].